Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wafa A. ALZlaiq"'
Autor:
Ibrahim M. Asiri, Dina Y. Alrastal, Rawan K. Alaqeel, Fawaz M. Alotaibi, Sawsan M. Kurdi, Dhafer M. Alshayban, Mohammed M. Alsultan, Bassem A. Almalki, Bashayer M. AlShehail, Wafa A. ALZlaiq, Mansour M. Alotaibi, Muteb S. Alanazi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 1, Pp 101924- (2024)
Background: The practice of dispensing drugs in primary healthcare centers has shifted to community pharmacies in Saudi Arabia. These changes increase demand and mandate improving their services; one such is establishing pharmacy drive-thru services.
Externí odkaz:
https://doaj.org/article/57937f95f8704b91a1ca3ec19da37697
Autor:
Mohamed H. ElSayed, Huda M. Atif, Mohamed Ahmed Eladl, Samah M. Elaidy, Ahmed M.N. Helaly, Fatma Azzahraa Hisham, Noha E. Farag, Noura M.S. Osman, Afaf T. Ibrahiem, Heba W.Z. Khella, Shymaa E. Bilasy, Marzough Aziz Albalawi, Mohamed A. Helal, Wafa Ali Alzlaiq, Sawsan A. Zaitone
Publikováno v:
Biomedicine & Pharmacotherapy. 164:114917
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e414e912ca166f5a9f91af1bd14a067
https://doi.org/10.1016/j.biopha.2023.114917
https://doi.org/10.1016/j.biopha.2023.114917
Autor:
Hala M. F. Mohammad, Mohamed Ahmed Eladl, Asmaa K. K. Abdelmaogood, Rabie E. Elshaer, Walaa Ghanam, Abdelhakeem Elaskary, Mohamed A. K. Saleh, Amira H. Eltrawy, Sahar K. Ali, Suzan M. M. Moursi, Shymaa E. Bilasy, Sawsan A. Zaitone, Wafa Ali Alzlaiq, Hayam Atteya
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3202 (2023)
The possible impact of topiramate against diabetic retinopathy (DREN) and its molecular mechanisms in relation to the nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome has not been studied before. Thus, in the present study, we
Externí odkaz:
https://doaj.org/article/2296404bc05c4a0a80a23f3fafb4b185
Autor:
Eman J. Heikal, Rashad M. Kaoud, Shadeed Gad, Hatem I. Mokhtar, Afaf A. Aldahish, Wafa Ali Alzlaiq, Sawsan A. Zaitone, Yasser M. Moustafa, Taha M. Hammady
Publikováno v:
Pharmaceuticals, Vol 16, Iss 6, p 795 (2023)
This study aimed to formulate a pharmaceutical dosage form containing omeprazole (OMP) and curcumin (CURC) to treat experimental peptic ulcers. OMP and CURC were preliminarily complexed with hydroxypropyl-β-cyclodextrin for enhancing their solubiliz
Externí odkaz:
https://doaj.org/article/d12c34129d0f4b4dab54acf700a4a816